JPY 1409.0
(-0.28%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 1.08 Billion JPY | 25.39% |
2022 | 865.03 Million JPY | 21.84% |
2021 | 709.95 Million JPY | 8.47% |
2020 | 654.5 Million JPY | 60.42% |
2019 | 408 Million JPY | 7.12% |
2018 | 380.88 Million JPY | -15.28% |
2017 | 449.58 Million JPY | 42.95% |
2016 | 314.5 Million JPY | 17.84% |
2015 | 266.89 Million JPY | 7.12% |
2014 | 249.16 Million JPY | 44.47% |
2013 | 172.46 Million JPY | -9.52% |
2012 | 190.62 Million JPY | 29.12% |
2011 | 147.63 Million JPY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 244 Million JPY | -21.36% |
2023 FY | 1.08 Billion JPY | 25.39% |
2023 Q3 | 247.09 Million JPY | -7.49% |
2023 Q1 | 260.21 Million JPY | -19.89% |
2023 Q2 | 267.09 Million JPY | 2.65% |
2023 Q4 | 310.27 Million JPY | 25.57% |
2022 Q4 | 324.8 Million JPY | 69.54% |
2022 FY | 865.03 Million JPY | 21.84% |
2022 Q3 | 191.57 Million JPY | 28.47% |
2022 Q2 | 149.12 Million JPY | -25.26% |
2022 Q1 | 199.53 Million JPY | -29.53% |
2021 FY | 709.95 Million JPY | 8.47% |
2021 Q2 | 155.35 Million JPY | -7.53% |
2021 Q4 | 283.14 Million JPY | 173.67% |
2021 Q1 | 167.99 Million JPY | -32.52% |
2021 Q3 | 103.46 Million JPY | -33.4% |
2020 Q1 | 104.21 Million JPY | -36.02% |
2020 Q2 | 93.43 Million JPY | -10.34% |
2020 FY | 654.5 Million JPY | 60.42% |
2020 Q3 | 207.92 Million JPY | 122.54% |
2020 Q4 | 248.94 Million JPY | 19.73% |
2019 Q1 | 85.8 Million JPY | -58.99% |
2019 FY | 408 Million JPY | 7.12% |
2019 Q2 | 77.7 Million JPY | -9.43% |
2019 Q4 | 162.87 Million JPY | 99.56% |
2019 Q3 | 81.61 Million JPY | 5.03% |
2018 Q4 | 209.2 Million JPY | 354.86% |
2018 Q2 | 49.93 Million JPY | -34.08% |
2018 Q1 | 75.74 Million JPY | -53.74% |
2018 FY | 380.88 Million JPY | -15.28% |
2018 Q3 | 45.99 Million JPY | -7.88% |
2017 Q3 | 86.84 Million JPY | 44.8% |
2017 FY | 449.58 Million JPY | 42.95% |
2017 Q1 | 139 Million JPY | 16.58% |
2017 Q4 | 163.75 Million JPY | 88.56% |
2017 Q2 | 59.97 Million JPY | -56.85% |
2016 Q4 | 119.23 Million JPY | 238.65% |
2016 FY | 314.5 Million JPY | 17.84% |
2016 Q3 | 35.2 Million JPY | -66.54% |
2016 Q2 | 105.23 Million JPY | 91.92% |
2016 Q1 | 54.83 Million JPY | -61.22% |
2015 Q2 | 67.72 Million JPY | 65.46% |
2015 Q4 | 141.4 Million JPY | 740.08% |
2015 Q3 | 16.83 Million JPY | -75.15% |
2015 FY | 266.89 Million JPY | 7.12% |
2015 Q1 | 40.93 Million JPY | -51.4% |
2014 FY | 249.16 Million JPY | 44.47% |
2014 Q4 | 84.22 Million JPY | 64.53% |
2014 Q3 | 51.19 Million JPY | -38.16% |
2014 Q2 | 82.78 Million JPY | 167.39% |
2014 Q1 | 30.96 Million JPY | -70.7% |
2013 Q1 | 16.26 Million JPY | -76.99% |
2013 Q3 | 38.78 Million JPY | 229.77% |
2013 Q4 | 105.66 Million JPY | 172.46% |
2013 FY | 172.46 Million JPY | -9.52% |
2013 Q2 | 11.76 Million JPY | -27.7% |
2012 FY | 190.62 Million JPY | 29.12% |
2012 Q2 | 41.5 Million JPY | 0.0% |
2012 Q3 | 36 Million JPY | -13.25% |
2012 Q4 | 70.68 Million JPY | 96.34% |
2011 FY | 147.63 Million JPY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Kitanotatsujin Corporation | 994.66 Million JPY | -9.05% |
Euglena Co., Ltd. | -2.67 Billion JPY | 140.488% |
Axas Holdings Co.,Ltd. | 31.37 Million JPY | -3357.468% |
C.I. Medical Co.,Ltd. | 2.08 Billion JPY | 47.902% |
Kao Corporation | 43.87 Billion JPY | 97.528% |
Niitaka Co., Ltd. | 705.93 Million JPY | -53.65% |
Rohto Pharmaceutical Co.,Ltd. | 30.93 Billion JPY | 96.494% |
Shiseido Company, Limited | 21.74 Billion JPY | 95.013% |
Lion Corporation | 14.62 Billion JPY | 92.583% |
Mandom Corporation | 2.6 Billion JPY | 58.298% |
Ivy Cosmetics Corporation | 160.31 Million JPY | -576.608% |
Milbon Co., Ltd. | 4 Billion JPY | 72.894% |
Nippon Shikizai, Inc. | 398.11 Million JPY | -172.455% |
Fancl Corporation | 8.83 Billion JPY | 87.72% |
KOSÉ Corporation | 11.66 Billion JPY | 90.7% |
Cota Co., Ltd. | 1.34 Billion JPY | 19.611% |
HABA Laboratories,Inc. | -2.11 Billion JPY | 151.197% |
C'bon Cosmetics Co.,Ltd. | -26.34 Million JPY | 4216.734% |
Pola Orbis Holdings Inc. | 9.66 Billion JPY | 88.777% |
Noevir Holdings Co., Ltd. | 7.67 Billion JPY | 85.864% |
Adjuvant Holdings Co.,Ltd. | -99.86 Million JPY | 1186.143% |
Almado, Inc. | 695.45 Million JPY | -55.966% |
I-ne CO., LTD. | 3.95 Billion JPY | 72.568% |
Premier Anti-Aging Co., Ltd. | -1.48 Billion JPY | 173.141% |
Liberta Co.,Ltd. | 111.33 Million JPY | -874.255% |
AXXZIA Inc. | 794.34 Million JPY | -36.549% |
S.T. Corporation | 1.27 Billion JPY | 14.861% |
Kobayashi Pharmaceutical Co., Ltd. | 20.33 Billion JPY | 94.667% |
Earth Corporation | 4.1 Billion JPY | 73.557% |
Sagami Rubber Industries Co., Ltd. | 40.95 Million JPY | -2548.396% |
Asahi Eito Holdings Co.,Ltd. | -623.21 Million JPY | 274.046% |
Ya-Man Ltd. | 398.33 Million JPY | -172.306% |
MTG Co., Ltd. | 1.98 Billion JPY | 45.329% |
TRANSACTION CO.,Ltd. | 3.76 Billion JPY | 71.18% |
SHOBIDO Corporation | 475.43 Million JPY | -128.144% |
Artnature Inc. | 1.46 Billion JPY | 25.809% |
Pigeon Corporation | 7.42 Billion JPY | 85.388% |
Unicharm Corporation | 86.05 Billion JPY | 98.74% |
Paltac Corporation | 20.63 Billion JPY | 94.744% |
CB GROUP MANAGEMENT Co., Ltd. | 2.05 Billion JPY | 47.269% |